Department of Biosciences, COMSATS University, Islamabad, Pakistan.
J Infect Public Health. 2020 Apr;13(4):598-605. doi: 10.1016/j.jiph.2019.08.019. Epub 2019 Sep 26.
Pseudomonas aeruginosa (member of ESKAPE group) is predominantly responsible for emerging nosocomial infections and poses serious health concern due to ever-increasing drug resistance trends. The current study investigates the prevalence of such highly resistant P. aeruginosa in major hospital settings and further characterizes and compares them for genetic heterogeneity.
Samples of patients (n=108) with wound infections, bacteremia and burn injuries from major hospitals of Rawalpindi and Islamabad during 2017 to 2018 were collected for the present study. The samples were processed in the COMSATS Microbiology and Public Health lab and screened for the P. aeruginosa by routinely used biochemical tests, drug susceptibility tests and rapid molecular approaches.
The results suggested that most of the isolates (88/108) are indeed P. aeruginosa (81.4%) underpinning the need of its active surveillance in hospital settings. Further analysis suggested that 32 of these 88 microbes are multi-drug resistance (36.3%), 16 (18.1%) are extensively drug resistance and 4 (4.5%) are pan-drug resistance. Moreover, double disc synergistic test suggested that 16 (18.1%) are positive for metallo-β-lactamase production. Molecular screening confirmed that 2 (12.5%) and 3 (18.75%) of these 16 isolates are positive for VIM and NDM gene respectively while all the studied isolates were positive for AmpC β-lactamase. PAP17 isolate harbors both VIM and NDM genes. ERIC PCR profiling showed that majority of MDR bacteria fall in cluster II and III similarly XDR bacteria also fall in cluster II and III while PDR bacteria fall in cluster IV.
This study revealed that majority of the isolates are multi drug resistant MDR and extensively drug resistant (XDR). However, the presence of some pan drug resistant (PDR) isolates among such small sample size screened is of utmost concern. Molecular typing of extremely resistant P. aeruginosa revealed high genetic diversity. Therefore, we suggest that regular monitoring and surveillance of such highly resistant P. aeruginosa in hospital settings will help to control their transmission and hence reduce the disease burden.
铜绿假单胞菌(ESKAPE 组的成员)主要负责新兴的医院感染,并由于不断增加的耐药趋势对健康构成严重威胁。本研究调查了主要医院环境中此类高度耐药铜绿假单胞菌的流行情况,并进一步对其进行了特征描述和遗传异质性比较。
本研究收集了 2017 年至 2018 年期间来自拉瓦尔品第和伊斯兰堡主要医院的伤口感染、菌血症和烧伤患者的样本(n=108)。样本在 COMSATS 微生物学和公共卫生实验室进行处理,通过常规使用的生化试验、药敏试验和快速分子方法筛选铜绿假单胞菌。
结果表明,大多数分离株(108/108)确实是铜绿假单胞菌(81.4%),这表明需要在医院环境中对其进行主动监测。进一步分析表明,这 88 个微生物中有 32 个是多药耐药(36.3%),16 个(18.1%)是广泛耐药,4 个(4.5%)是全耐药。此外,双碟协同试验表明,16 个(18.1%)产金属β-内酰胺酶阳性。分子筛选证实,这 16 个分离株中的 2 个(12.5%)和 3 个(18.75%)分别为 VIM 和 NDM 基因阳性,而所有研究的分离株均为 AmpC β-内酰胺酶阳性。PAP17 分离株同时携带 VIM 和 NDM 基因。ERIC-PCR 谱分析显示,大多数多药耐药菌(MDR)落入 II 类和 III 类聚类,同样,广泛耐药菌(XDR)也落入 II 类和 III 类聚类,而完全耐药菌(PDR)落入 IV 类聚类。
本研究表明,大多数分离株为多药耐药 MDR 和广泛耐药(XDR)。然而,在如此小的样本量筛选中,存在一些泛耐药(PDR)分离株是极其令人关注的。对极其耐药铜绿假单胞菌的分子分型显示出高度的遗传多样性。因此,我们建议定期监测和监控医院环境中此类高度耐药铜绿假单胞菌,有助于控制其传播,从而减轻疾病负担。